Normunity is a biotechnology company developing anti-cancer therapies that target novel tumor-specific mechanisms to engage T cells and suppress immune evasion in solid tumors.

Enterpret is an AI-enabled platform that centralizes and analyzes customer feedback to enhance collaboration between product, marketing, and sales teams.

Nivoda is a digital marketplace and supply chain platform for the diamond and jewelry industry, providing jewelers with access to a vast inventory and streamlined purchasing processes.

Glooko, Inc. provides a digital health platform focused on improving health outcomes for people with chronic conditions through data insights and device integrations.

Safire Technology Group, Inc. develops a patented electrolyte technology that enhances the safety of Lithium-ion batteries by preventing fires through a liquid-to-solid transformation upon impact.

AttoTude develops high-speed interconnect technology for AI and hyperscale data centers, enhancing speed, power, reliability, and cost efficiency.

Quantum Circuits develops high-fidelity quantum computers with intrinsic error detection and handling.

Otto is a fintech company that offers a financial health platform focused on efficient debt management and repayment, utilizing machine learning to provide personalized repayment strategies and a consolidated view of users' debts.

Joor is a digital wholesale ecosystem company that provides a platform for fashion brands and retailers to streamline the process of presenting collections, placing orders, and handling billing and payment.

Agomab Therapeutics is a Belgian biotech company developing novel treatments for fibrosis, with a pipeline of growth factor targeting antibodies and small molecule compounds.

Acesion Pharma is a biotech company that develops therapies for atrial fibrillation, specifically focusing on the clinical development of an SK ion channel inhibitor for chronic oral treatment.

Diligent is a robotics company that develops and deploys the Moxi nursing robot, designed to assist healthcare providers by improving workflows and potentially integrating with electronic medical records.

Actio Biosciences is a biotechnology company that uses its proprietary platform for genetics and precision medicine to develop therapeutics for both rare and common diseases, with a focus on TRPV4 mutations for the treatment of Charcot-Marie-Tooth disease type 2C and other serious bone diseases.